During the last session, Tandem Diabetes Care Inc (NASDAQ:TNDM)’s traded shares were 0.41 million, with the beta value of the company hitting 1.34. At the end of the trading day, the stock’s price was $31.78, reflecting an intraday gain of 5.41% or $1.63. The 52-week high for the TNDM share is $53.69, that puts it down -68.94 from that peak though still a striking 43.77% gain since the share price plummeted to a 52-week low of $17.87. The company’s market capitalization is $2.09B, and the average intraday trading volume over the past 10 days was 2.03 million shares, and the average trade volume was 1.31 million shares over the past three months.
Tandem Diabetes Care Inc (TNDM) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.78. TNDM has a Sell rating from 1 analyst(s) out of 10 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 8 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Tandem Diabetes Care Inc (TNDM) registered a 5.41% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.41% in intraday trading to $31.78, hitting a weekly high. The stock’s 5-day price performance is 11.16%, and it has moved by -1.15% in 30 days. Based on these gigs, the overall price performance for the year is 72.62%. The short interest in Tandem Diabetes Care Inc (NASDAQ:TNDM) is 8.39 million shares and it means that shorts have 6.85 day(s) to cover.
The consensus price target of analysts on Wall Street is $58, which implies an increase of 45.21% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $36 and $160 respectively. As a result, TNDM is trading at a discount of -403.46% off the target high and -13.28% off the low.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Statistics show that Tandem Diabetes Care Inc has underperformed its competitors in share price, compared to the industry in which it operates. Tandem Diabetes Care Inc (TNDM) shares have gone down -36.03% during the last six months, with a year-to-date growth rate less than the industry average at -10.19% against 15.40. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 10.24% this quarter and then jump 30.50% in the quarter after that. In the rating firms’ projections, revenue will increase 21.37% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 251.5M as predicted by 18 analyst(s). Meanwhile, a consensus of 13 analyst(s) estimates revenue growth to 221.9M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 196.8M and 191.67M respectively. In this case, analysts expect current quarter sales to grow by 27.80% and then jump by 15.77% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -6.11%. While earnings are projected to return 50.65% in 2024, the next five years will return 16.00% per annum.
TNDM Dividends
Tandem Diabetes Care Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Tandem Diabetes Care Inc insiders own 0.77% of total outstanding shares while institutional holders control 114.07%, with the float percentage being 114.95%. BLACKROCK INC. is the largest shareholder of the company, while 449.0 institutions own stock in it. As of 2024-06-30, the company held over 11.12 million shares (or 17.1137% of all shares), a total value of $448.14 million in shares.
The next largest institutional holding, with 7.38 million shares, is of VANGUARD GROUP INC’s that is approximately 11.3518% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $297.26 million.
Also, the Mutual Funds coming in first place with the largest holdings of Tandem Diabetes Care Inc (TNDM) shares are Smallcap World Fund and iShares Core S&P Smallcap ETF. Data provided on Jun 30, 2024 indicates that Smallcap World Fund owns about 4.27 shares. This amounts to just over 6.50 percent of the company’s overall shares, with a $135.91 million market value. The same data shows that the other fund manager holds slightly less at 4.17, or about 6.35% of the stock, which is worth about $132.71 million.
